NCT02911948 - A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

September 21, 2016

Primary Completion Date

November 17, 2017

Study Completion Date

November 22, 2017

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

Insulin degludec/liraglutide

Injected s.c. / subcutaneously (under the skin) once daily

DRUG

Insulin degludec

Injected s.c. / subcutaneously (under the skin) once daily

Trial Locations (38)

1430015

Novo Nordisk Investigational Site, Ota-ku, Tokyo

078-8211

Novo Nordisk Investigational Site, Asahikawa-shi, Hokkaido

253-0044

Novo Nordisk Investigational Site, Chigasaki-shi, Kanagawa

066-0032

Novo Nordisk Investigational Site, Chitose, Hokkaido

101-0024

Novo Nordisk Investigational Site, Chiyoda-ku, Tokyo

251-0041

Novo Nordisk Investigational Site, Fujisawa-shi, Kanagawa

918-8503

Novo Nordisk Investigational Site, Fukui-shi, Fukui

830 8522

Novo Nordisk Investigational Site, Fukuoka

810-0001

Novo Nordisk Investigational Site, Fukuoka-shi, Fukuoka

819-0006

Novo Nordisk Investigational Site, Fukuoka-shi, Fukuoka

963-8851

Novo Nordisk Investigational Site, Fukushima

060-0062

Novo Nordisk Investigational Site, Hokkaido

311-0113

Novo Nordisk Investigational Site, Ibaraki

235-0045

Novo Nordisk Investigational Site, Kanagawa

582-0005

Novo Nordisk Investigational Site, Kashiwara-shi, Osaka

350-0851

Novo Nordisk Investigational Site, Kawagoe-shi, Saitama

332-0012

Novo Nordisk Investigational Site, Kawaguchi-shi, Saitama

862-0976

Novo Nordisk Investigational Site, Kumamoto

862-0965

Novo Nordisk Investigational Site, Kumamoto-shi, Kumamoto

181-0013

Novo Nordisk Investigational Site, Mitaka-shi, Tokyo

880-0034

Novo Nordisk Investigational Site, Miyazaki

390-8621

Novo Nordisk Investigational Site, Nagano

901-2393

Novo Nordisk Investigational Site, Nakagami, Okinawa

Unknown

Novo Nordisk Investigational Site, Neyagawa-shi, Osaka

950 1104

Novo Nordisk Investigational Site, Niigata-shi, Niigata

831-0016

Novo Nordisk Investigational Site, Okawa-shi, Fukuoka

569-1045

Novo Nordisk Investigational Site, Osaka

536-0001

Novo Nordisk Investigational Site, Osaka-shi, Osaka

336-0967

Novo Nordisk Investigational Site, Saitama-shi, Saitama

980-0021

Novo Nordisk Investigational Site, Sendai-shi, Miyagi

329-0433

Novo Nordisk Investigational Site, Shimotsuke-shi, Tochigi

323-0022

Novo Nordisk Investigational Site, Tochigi

103-0027

Novo Nordisk Investigational Site, Tokyo

103-0028

Novo Nordisk Investigational Site, Tokyo

113-8431

Novo Nordisk Investigational Site, Tokyo

901-0243

Novo Nordisk Investigational Site, Tomigusuku-shi, Okinawa

901-0244

Novo Nordisk Investigational Site, Tomigusuku-shi, Okinawa

754-0002

Novo Nordisk Investigational Site, Yamaguchi-shi, Yamaguchi